51 results

Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial

Harrison, Claire N.; Schaap, Nicolaas; Vannucchi, Alessandro M.; More

HemaSphere. 5(5):e562, May 2021.

Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial

Mesa, Ruben A.; Schaap, Nicolaas; Vannucchi, Alessandro M.; More

HemaSphere. 5(5):e553, May 2021.

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

Feld, Jonathan; Tremblay, Douglas; Dougherty, Mikaela; More

HemaSphere. 5(4):e549, April 2021.

Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

Gálvez, Eva; Vallespín, Elena; Arias-Salgado, Elena G.; More

HemaSphere. 5(4):e539, April 2021.

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation

Brauer, Dominic; Backhaus, Donata; Pointner, Rosmarie; More

HemaSphere. 5(3):e532, March 2021.

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection

Banck, Jan Christoph; Mueller, Niklas; Mellinghoff, Sibylle Christiane; More

HemaSphere. 5(3):e530, March 2021.

Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies

Hayette, Sandrine; Grange, Béatrice; Vallee, Maxime; More

HemaSphere. 5(2):e522, February 2021.

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Gisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; More

HemaSphere. 4(6):e485, December 2020.

Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia

Fontana, Diletta; Ramazzotti, Daniele; Aroldi, Andrea; More

HemaSphere. 4(6):e497, December 2020.

Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7

Kunimoto, Hiroyoshi; Fukuchi, Yumi; Murakami, Koichi; More

HemaSphere. 4(5):e469, October 2020.

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience

Mossuto, Sandra; Attardi, Enrico; Alesiani, Francesco; More

HemaSphere. 4(5):e483, October 2020.

Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia

Øbro, Nina F.; Grinfeld, Jacob; Belmonte, Miriam; More

HemaSphere. 4(3):e371, June 2020.

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia

Depreter, Barbara; De Moerloose, Barbara; Vandepoele, Karl; More

HemaSphere. 4(2):e346, April 2020.

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

Schumich, Angela; Prchal-Murphy, Michaela; Maurer-Granofszky, Margarita; More

HemaSphere. 4(1):e312, February 2020.

The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model

Bertuccio, Salvatore Nicola; Boudia, Fabien; Cambot, Marie; More

HemaSphere. 4(1):e319, February 2020.

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; More

HemaSphere. 3(6):e321, December 2019.

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

Terpos, Evangelos; Kostopoulos, Ioannis V.; Kastritis, Efstathios; More

HemaSphere. 3(6):e300, December 2019.

Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

Cattaneo, Chiara; Busca, Alessandro; Gramegna, Doriana; More

HemaSphere. 3(6):e320, December 2019.

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group

Blais, S.; Boutroux, H.; Pasquet, M.; More

HemaSphere. 3(6):e316, December 2019.